<code id='90A8D56DFD'></code><style id='90A8D56DFD'></style>
    • <acronym id='90A8D56DFD'></acronym>
      <center id='90A8D56DFD'><center id='90A8D56DFD'><tfoot id='90A8D56DFD'></tfoot></center><abbr id='90A8D56DFD'><dir id='90A8D56DFD'><tfoot id='90A8D56DFD'></tfoot><noframes id='90A8D56DFD'>

    • <optgroup id='90A8D56DFD'><strike id='90A8D56DFD'><sup id='90A8D56DFD'></sup></strike><code id='90A8D56DFD'></code></optgroup>
        1. <b id='90A8D56DFD'><label id='90A8D56DFD'><select id='90A8D56DFD'><dt id='90A8D56DFD'><span id='90A8D56DFD'></span></dt></select></label></b><u id='90A8D56DFD'></u>
          <i id='90A8D56DFD'><strike id='90A8D56DFD'><tt id='90A8D56DFD'><pre id='90A8D56DFD'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:363
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Liver decline slowed by off
          Liver decline slowed by off

          AdobeWASHINGTON—TherearethreeFDA-approveddrugsfortreatingalcoholusedisorder.Butadifferentmedication,

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

          MollyFerguson/STATThoughtsaboutCytokineticsafterWednesdaynight’sfinancingannouncement:1.Managementis